Polyethylene Glycol Hydrogel

DEVICE2 trials

Sponsors

University of Washington, OHSU Knight Cancer Institute

Conditions

Bladder CarcinomaBreast CarcinomaHead and Neck CarcinomaRadiation-Induced Dermatitis

Unknown Phase

TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer

CompletedNCT03125226

University of WashingtonBladder Carcinoma

Start: 2017-10-05End: 2020-05-18Updated: 2021-02-25

StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients

WithdrawnNCT05073172

OHSU Knight Cancer InstituteBreast Carcinoma, Head and Neck Carcinoma, Radiation-Induced Dermatitis

Start: 2024-01-01End: 2025-07-01Updated: 2024-05-06

Related Papers

TraceIT: A prospective pilot study of a temporary intravesical fiducial marker for bladder cancer radiation therapy.

Journal of Clinical Oncology2021-02-203 citations

MP38-13 INJECTABLE HYDROGEL AS A TEMPORARY INTRAVESICAL FIDUCIAL MARKER FOR BLADDER CANCER RADIATION THERAPY: SAFETY AND FEASIBILITY FROM A PROSPECTIVE PILOT STUDY

The Journal of Urology2019-04-011 citations